KRTX
Karuna Therapeutics Inc
Price:  
329.83 
USD
Volume:  
1,868,420.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

KRTX WACC - Weighted Average Cost of Capital

The WACC of Karuna Therapeutics Inc (KRTX) is 5.5%.

The Cost of Equity of Karuna Therapeutics Inc (KRTX) is 6.05%.
The Cost of Debt of Karuna Therapeutics Inc (KRTX) is 5.00%.

Range Selected
Cost of equity 5.40% - 6.70% 6.05%
Tax rate -% - 0.10% 0.05%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.2% - 5.9% 5.5%
WACC

KRTX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.33 0.33
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.40% 6.70%
Tax rate -% 0.10%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 5.2% 5.9%
Selected WACC 5.5%